PEPTIDE FRAGMENT
LYS-PRO-VAL
KPV is a three-amino-acid peptide sequence composed of lysine, proline, and valine and corresponds to the C-terminal region of alpha-MSH.
PEPTIDE PERFORMANCE RESEARCH LIBRARY
KPV RESEARCH.
An educational overview of KPV, a short peptide fragment derived from alpha-melanocyte-stimulating hormone and studied primarily in laboratory and animal models involving inflammatory signaling, epithelial biology, and antimicrobial activity.
RESEARCH OVERVIEW
WHAT IS KPV?
INFLAMMATION RESEARCH
IMMUNE SIGNALING
Experimental studies have investigated KPV in models involving inflammatory signaling, cytokine activity, and cellular responses associated with tissue irritation.
EVIDENCE STATUS
PRIMARILY PRECLINICAL
Most research remains laboratory or animal based. Human clinical evidence is limited and does not establish an approved therapeutic role.
MECHANISMS UNDER INVESTIGATION
INFLAMMATION, BARRIER & CELL SIGNALING.
Researchers have examined KPV in models involving inflammatory signaling and epithelial tissue biology, but these mechanisms remain experimental.
NF-κB SIGNALING
Preclinical studies have explored possible effects on inflammatory transcription pathways, including NF-κB-related signaling.
EPITHELIAL BARRIER
KPV has been studied in experimental intestinal and epithelial models involving barrier integrity, inflammatory stress, and cellular transport.
ANTIMICROBIAL RESEARCH
Laboratory work has also examined antimicrobial properties of KPV and related melanocortin-derived peptide sequences.
CURRENT EVIDENCE
WHAT HAS BEEN STUDIED?
ANIMAL MODELS
INFLAMMATORY RESEARCH
Animal studies have investigated KPV-related effects in models of intestinal inflammation, tissue irritation, and inflammatory signaling.
CELLULAR RESEARCH
EPITHELIAL SYSTEMS
Cell and tissue models have examined uptake, barrier-related processes, inflammatory responses, and antimicrobial activity.
IMPORTANT CONTEXT
LIMITED HUMAN DATA
Existing preclinical findings do not establish clinical effectiveness, long-term safety, or a validated human-use framework.
RESEARCH LIMITATIONS
WHERE THE EVIDENCE IS STILL LIMITED.
KPV research remains largely preclinical, and findings from cellular or animal models cannot automatically be translated into clinical outcomes in humans.
Questions remain regarding pharmacokinetics, route-specific effects, long-term safety, clinical effectiveness, and the reproducibility of findings across human populations.
RESEARCH SOURCES
PUBLISHED REFERENCES.
Melanocortin-Derived Peptide Research
Published studies have examined the C-terminal KPV sequence
of alpha-MSH in inflammatory and antimicrobial models.
Intestinal Inflammation Models
Experimental research has evaluated KPV in epithelial and
colitis-related models involving inflammatory signaling and
barrier function.
Antimicrobial Research
Laboratory work has investigated antimicrobial activity
associated with KPV and related alpha-MSH-derived sequences.
EDUCATIONAL RESEARCH NOTICE
Information presented in the Peptide Performance Research Library is provided for general educational and scientific reference purposes only.
This content is not medical advice, diagnosis, treatment guidance, dosing information, or personal-use instruction. Research findings may change as additional evidence becomes available.